Dr Panagiotis Kottaridis
Acute myeloid leukaemia (AML), myelodysplasia, chronic myeloid leukaemia (CML), bone marrow transplantation, late effects of treatment
HCA Healthcare UK at University College Hospital, 5th Floor, Macmillan Cancer Centre, Huntley Street, London WC1E 6AG; Wellington Hospital (Platinum Medical Centre, 15-17 Lodge Road, NW8 8NX); The Royal Free Hospital, Pond Street, London, NW3 2QG
Leukaemias, haemato-oncology, bone marrow transplantation, late effects of chemotherapy
Dr Panos Kottaridis is a consultant haematologist in leukaemia and bone marrow transplantation. Since 2004 he has lead the AML/myelodysplasia/CML service at the Royal Free Hospital. His main academic and clinical interests focus on prognostication of AML, haemato-oncology, bone marrow transplantation, and the late effects of chemotherapy and bone marrow transplantation. Dr Kottaridis is a core member of the AML working party of the National Cancer Research Institute and has published more than 65 papers in peer reviewed journals. His work has been cited by more than 3000 scientific papers and Dr Kottaridis has delivered talks as a guest speaker or presenter in national and international meetings. He has always been an enthusiastic teacher and for the last 6 years has been in charge of the undergraduate teaching programme at The Royal Free Campus of UCL Medical School.
Dr Kottaridis also performs autologous stem cell transplants for the treatment of Multiple Sclerosis.